Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b

被引:40
作者
Hamidi, M. [1 ]
Zarrin, A. H. [1 ]
Foroozesh, M. [1 ]
Zarei, N. [1 ]
Mohammadi-Samani, S. [1 ]
机构
[1] Shiraz Univ Med Sci, Fac Pharm, Dept Pharmaceut, Shiraz, Iran
关键词
interferon; interferon-alpha; 2b; carrier erythrocytes; hypotonic preswelling;
D O I
10.1016/j.ijpharm.2007.04.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-alpha 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33 +/- 1588.35 IU/0.1 ml, 14.53 +/- 2.94%, and 83.61 +/- 0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 36 条
[1]   PHARMACOKINETICS AND TISSUE UPTAKE OF DOXORUBICIN ASSOCIATED WITH ERYTHROCYTE-MEMBRANE - ERYTHROCYTE-GHOSTS VS ERYTHROCYTE-VESICLES [J].
ALACHI, A ;
BOROUJERDI, M .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (15) :2199-2219
[2]  
ALHASSO S, 2001, INTERFERONS OVERVIEW, V26
[3]   ENTRY OF FERRITIN INTO HUMAN RED CELLS DURING HYPOTONIC HAEMOLYSIS [J].
BAKER, RF .
NATURE, 1967, 215 (5099) :424-&
[4]  
BANKER GS, 2002, MODERN PHARM, P560
[5]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[6]  
Basler Christopher F, 2002, Int Rev Immunol, V21, P305
[7]  
Berman J. D., 1987, ADV BIOSCI, V67, P145
[8]   THE ENCAPSULATION OF INSULIN IN ERYTHROCYTES [J].
BIRD, J ;
BEST, R ;
LEWIS, DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (04) :246-247
[9]  
Deloach J. R., 1987, ADV BIOSCI, V67, P199
[10]  
ERCHLER HC, 1987, ADV BIOSCI SER, V67, P11